Replies to post #61594 on Avid Bioservices Inc (CDMO)

[biopharm]

4 Presentations at AACR allows some analysts to initiate coverage on Peregrine with a buy and target price.

Who will be the smart analysts out there that will jump on board and be the early adopters of Peregrine instead of the laggards and jump on in after we've made our big move upward?

Lets go Analysts.... start earning your paycheck